MedWatch

Novo management sees lower risk and opportunity

According to the Novo Nordisk management team, the company’s businesses are less exposed to risks now than in the beginning of 2017 and this has led to a narrowing of its full year guidance. But at the same time, the opportunities for this year have decreased, according to CEO Lars Fruergaard Jørgensen.

Foto: /ritzau/Melissa Kühn Hjerrild

Wednesday morning, Novo Nordisk presented a surprisingly strong quarterly report which even gave cause for slight raising of the expectations for 2017.

“We expected 2017 to be a challenging year with significant competition, and that’s also what we realize now. We set a broader range because it was also an opportunity to do even better. Four months into the year, we see that we deliver according to plan, so we fell that it’s prudent to narrow the range a bit as the risk is lower, but the opportunity is also lower” said CEO Lars Fruergaard Jørgensen on a conference call after the publication of Novo’s Q1 account.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier